You just read:

Janssen Enters Immunotherapy Clinical Collaboration with Bristol-Myers Squibb to Evaluate daratumumab (DARZALEX®) in Combination with nivolumab (OPDIVO®)

News provided by

Janssen Biotech, Inc.

05 Jan, 2017, 06:59 ET